Țară: Canada
Limbă: engleză
Sursă: Health Canada
VANCOMYCIN HYDROCHLORIDE
PHARMASCIENCE INC
A07AA09
VANCOMYCIN
250MG
CAPSULE
VANCOMYCIN HYDROCHLORIDE 250MG
ORAL
20/100
Prescription
GLYCOPEPTIDES
Active ingredient group (AIG) number: 0105837006; AHFS:
APPROVED
2014-08-22
PRODUCT MONOGRAPH PR PMSC-VANCOMYCIN Vancomycin Hydrochloride Capsules, USP 125 mg and 250 mg ANTIBIOTIC PHARMASCIENCE INC. 6111 Royalmount Ave., Suite 100 Montréal, Québec H4P 2T4 DATE OF REVISION: APR 25, 2023 www.pharmascience.com Submission Control No.: 273794 _pmsc-VANCOMYCIN Product Monograph _ _Page 2 of 23_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ............................................................ 3 SUMMARY PRODUCT INFORMATION ................................................................................. 3 INDICATIONS AND CLINICAL USE ...................................................................................... 3 CONTRAINDICATIONS ............................................................................................................ 4 WARNINGS AND PRECAUTIONS .......................................................................................... 4 ADVERSE REACTIONS ............................................................................................................ 6 DRUG INTERACTIONS ............................................................................................................. 7 DOSAGE AND ADMINISTRATION ......................................................................................... 7 OVERDOSAGE ........................................................................................................................... 8 ACTION AND CLINICAL PHARMACOLOGY ....................................................................... 8 STORAGE AND STABILITY .................................................................................................... 8 DOSAGE FORMS, COMPOSITION AND PACKAGING ........................................................ 9 PART II: SCIENTIFIC INFORMATION ................................................................................... 10 PHARMACEUTICAL INFORMATION .................................................................................. 10 DETAILED PHARMACOLOGY ................................ Citiți documentul complet